CANSINO BIOLOGICS INCCANSINO BIOLOGICS INCCANSINO BIOLOGICS INC

CANSINO BIOLOGICS INC

No trades
See on Supercharts
Market capitalization
‪842.05 M‬USD
−0.85USD
‪−209.77 M‬USD
‪48.83 M‬USD
‪113.55 M‬
Beta (1Y)
1.88

About CANSINO BIOLOGICS INC

CEO
Xue Feng Yu
Headquarters
Tianjin
Employees (FY)
‪1.49 K‬
Founded
2009
ISIN
CNE100003F01
FIGI
BBG00QLDXKX3
CanSino Biologics, Inc. engages in the research and development, manufacturing, and sale of vaccines. It offers shingles, meningitis, polio, adenovirus, and tuberculosis vaccines. The company was founded by Xuan Liu, Xue Feng Yu, Tao Zhu, Dong Xu Qiu and Hui Hua Mao on January 13, 2009 and is headquartered in Tianjin, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CASBF is 2.10 USD — it has increased by 12.90% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange CANSINO BIOLOGICS INC stocks are traded under the ticker CASBF.
CANSINO BIOLOGICS INC is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.
CASBF stock is 11.43% volatile and has beta coefficient of 1.88. Check out the list of the most volatile stocks — is CANSINO BIOLOGICS INC there?
One year price forecast for CANSINO BIOLOGICS INC has a max estimate of 3.58 USD and a min estimate of 2.36 USD.
CASBF earnings for the last quarter are −0.08 USD per share, whereas the estimation was −0.03 USD resulting in a −171.73% surprise. The estimated earnings for the next quarter are −0.20 USD per share. See more details about CANSINO BIOLOGICS INC earnings.
CANSINO BIOLOGICS INC revenue for the last quarter amounts to ‪20.50 M‬ USD despite the estimated figure of ‪16.26 M‬ USD. In the next quarter revenue is expected to reach ‪26.86 M‬ USD.
Yes, you can track CANSINO BIOLOGICS INC financials in yearly and quarterly reports right on TradingView.
CASBF stock has risen by 12.90% compared to the previous week, the month change is a 8.50% fall, over the last year CANSINO BIOLOGICS INC has showed a 58.17% decrease.
CASBF net income for the last quarter is ‪−68.88 M‬ USD, while the quarter before that showed ‪−19.79 M‬ USD of net income which accounts for −248.02% change. Track more CANSINO BIOLOGICS INC financial stats to get the full picture.
Today CANSINO BIOLOGICS INC has the market capitalization of ‪451.73 M‬, it has decreased by 5.03% over the last week.
Like other stocks, CASBF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CANSINO BIOLOGICS INC stock right from TradingView charts — choose your broker and connect to your account.
CASBF reached its all-time high on May 18, 2020 with the price of 59.99 USD, and its all-time low was 1.86 USD and was reached on Mar 26, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has ‪1.49 K‬ employees. See our rating of the largest employees — is CANSINO BIOLOGICS INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CANSINO BIOLOGICS INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CANSINO BIOLOGICS INC stock shows the sell signal. See more of CANSINO BIOLOGICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on CANSINO BIOLOGICS INC future price: according to them, CASBF price has a max estimate of 3.58 USD and a min estimate of 2.36 USD. Read a more detailed CANSINO BIOLOGICS INC forecast: see what analysts think of CANSINO BIOLOGICS INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CANSINO BIOLOGICS INC EBITDA is ‪−258.57 M‬ USD, and current EBITDA margin is −552.08%. See more stats in CANSINO BIOLOGICS INC financial statements.